The store will not work correctly when cookies are disabled.
3-Amino-N7-(beta-D-ribofuranosyl)-pyrrolo[2,3-d]pyrimidine
ID: ALA5207667
PubChem CID: 168297248
Max Phase: Preclinical
Molecular Formula: C12H15N3O4
Molecular Weight: 265.27
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1cnc2c(ccn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1
Standard InChI: InChI=1S/C12H15N3O4/c13-7-3-6-1-2-15(11(6)14-4-7)12-10(18)9(17)8(5-16)19-12/h1-4,8-10,12,16-18H,5,13H2/t8-,9-,10-,12-/m1/s1
Standard InChI Key: CUICMNYNTGBVDV-DNRKLUKYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
-1.4878 0.4048 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.9727 -0.2626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7976 -0.2626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2101 0.4518 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4878 -0.9300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7427 -1.7146 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7032 -0.6751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0357 -1.1600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7032 0.1498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0357 0.6347 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7488 0.3797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0843 -0.3738 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9048 -0.4600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3897 0.2073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2101 0.1211 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0541 0.9610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2337 1.0471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7488 1.7146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0357 1.4597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 1
3 4 1 0
2 5 1 0
5 6 1 6
7 5 1 0
7 8 1 6
9 7 1 0
1 9 1 0
9 10 1 1
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
14 16 2 0
17 16 1 0
11 17 2 0
18 17 1 0
19 18 2 0
19 10 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 265.27 | Molecular Weight (Monoisotopic): 265.1063 | AlogP: -0.77 | #Rotatable Bonds: 2 |
Polar Surface Area: 113.76 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.46 | CX Basic pKa: 4.52 | CX LogP: -1.17 | CX LogD: -1.17 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.57 | Np Likeness Score: 0.77 |
References
1. Lin C, Jaén Batista DDG, Mazzeti AL, Donola Girão R, de Oliveira GM, Karalic I, Hulpia F, Soeiro MNC, Maes L, Caljon G, Van Calenbergh S.. (2022) N6-modification of 7-Deazapurine nucleoside analogues as Anti-Trypanosoma cruzi and anti-Leishmania agents: Structure-activity relationship exploration and In vivo evaluation., 231 [PMID:35144125] [10.1016/j.ejmech.2022.114165] |